Coexpression of CXCR4 and MMP9 Predicts Lung Metastasis and Poor Prognosis in Resected Osteosarcoma

Overview

Journal Tumour Biol

Publisher Sage Publications

Specialty Oncology

Date 2015 Nov 8

PMID 26546437

Citations 30

Authors

Zhiwu Ren

Shoulei Liang

Jilong Yang

Xiuxin Han

Luling Shan

Biying Wang

Tianyang Mu

Yanqin Zhang

Xueli Yang

Shunbin Xiong

Guowen Wang

Affiliations

Soon will be listed here.

Abstract

Osteosarcoma is a highly aggressive bone disease with a tendency to metastasize to the lung. The 5-year survival of patients with metastatic osteosarcoma is only 20 %. Many studies have demonstrated SDF-1/CXCR4 and MMP9 play important roles in the metastasis of malignant tumors, including osteosarcoma. The aim of this study was to investigate the association of CXCR4 and MMP9 expression with clinicopathological features and pulmonary metastasis in osteosarcoma. Using tumor tissue microarrays, we analyzed the expression of CXCR4 and MMP9 among 34 primary osteosarcomas with pulmonary metastasis and 62 primary osteosarcomas without metastasis. A median time of 57.5 months (range: 6 to 171 months) follow-up was performed to evaluate tumor metastasis and the patient survival. The prognostic values were determined by univariate Kaplan-Meier survival analysis and multivariate Cox proportional hazard model analysis. The accuracy of oncologic outcome prediction was evaluated by receiver-operating characteristics (ROC) curves (AUC). The expression of CXCR4 and MMP9 was significantly correlated in tumor tissues (P = 0.026). Both CXCR4 and MMP9 were independent predictors for overall survival and metastasis-free survival by Cox multivariate analysis, and high expression for both CXCR4 and MMP9 were even more significant and better biomarkers for osteosarcoma metastasis and survival. The combination of CXCR4 and MMP9 high expression is very likely to be a valuable independent predictor of lung metastasis and survival in osteosarcoma patients.

Citing Articles

Osteoid cell-derived chemokines drive bone-metastatic prostate cancer.

Johnson C, Cook L Front Oncol. 2023; 13:1100585.

PMID: 37025604 PMC: 10070788. DOI: 10.3389/fonc.2023.1100585.

Clinicopathological and prognostic significance of CXCR4 expression in osteosarcoma: a meta-analysis.

Kusuma I, Yapson G, Nolan J, Wiratnaya I, Supadmanaba I Biomedicine (Taipei). 2023; 12(4):34-43.

PMID: 36816176 PMC: 9910227. DOI: 10.37796/2211-8039.1360.

Up-regulation of matrix metalloproteinase-9 in primary bone tumors and its association with tumor aggressiveness.

Vaezi M, Eghtedari A, Safizadeh B, Ghasempour G, Salimi V, Nourbakhsh M Mol Biol Rep. 2022; 49(10):9409-9427.

PMID: 36002655 DOI: 10.1007/s11033-022-07798-z.

Lung Immune Prognostic Index Could Predict Metastasis in Patients With Osteosarcoma.

He X, Wang Y, Ye Q, Wang Y, Min L, Luo Y Front Surg. 2022; 9:923427.

PMID: 35874141 PMC: 9304694. DOI: 10.3389/fsurg.2022.923427.

Text-Mining Approach to Identify Hub Genes of Cancer Metastasis and Potential Drug Repurposing to Target Them.

Saha Detroja T, Gil-Henn H, Samson A J Clin Med. 2022; 11(8).

PMID: 35456223 PMC: 9029557. DOI: 10.3390/jcm11082130.

References

Baldwin R, Haghandish N, Daneshmand M, Amin S, Paris G, Falls T . Protein arginine methyltransferase 7 promotes breast cancer cell invasion through the induction of MMP9 expression. Oncotarget. 2015; 6(5):3013-32. PMC: 4413634. DOI: 10.18632/oncotarget.3072. View

Bacci G, Rocca M, Salone M, Balladelli A, Ferrari S, Palmerini E . High grade osteosarcoma of the extremities with lung metastases at presentation: treatment with neoadjuvant chemotherapy and simultaneous resection of primary and metastatic lesions. J Surg Oncol. 2008; 98(6):415-20. DOI: 10.1002/jso.21140. View

Nian W, Chen F, Ao X, Chen Z . CXCR4 positive cells from Lewis lung carcinoma cell line have cancer metastatic stem cell characteristics. Mol Cell Biochem. 2011; 355(1-2):241-8. DOI: 10.1007/s11010-011-0860-z. View

Wagner P, Hyjek E, Vazquez M, Meherally D, Liu Y, Chadwick P . CXCL12 and CXCR4 in adenocarcinoma of the lung: association with metastasis and survival. J Thorac Cardiovasc Surg. 2009; 137(3):615-21. DOI: 10.1016/j.jtcvs.2008.07.039. View

Choi S, Lee H, Jin Y, Jang J, Kang G, Lee M . MMP9 processing of HSPB1 regulates tumor progression. PLoS One. 2014; 9(1):e85509. PMC: 3896397. DOI: 10.1371/journal.pone.0085509. View

Shuman Moss L, Jensen-Taubman S, Stetler-Stevenson W . Matrix metalloproteinases: changing roles in tumor progression and metastasis. Am J Pathol. 2012; 181(6):1895-9. PMC: 3506216. DOI: 10.1016/j.ajpath.2012.08.044. View

Lee C, Lai J, Hueng D, Ma H, Chung Y, Sun Y . Disrupting the CXCL12/CXCR4 axis disturbs the characteristics of glioblastoma stem-like cells of rat RG2 glioblastoma. Cancer Cell Int. 2013; 13(1):85. PMC: 3765790. DOI: 10.1186/1475-2867-13-85. View

Oda Y, Yamamoto H, Tamiya S, Matsuda S, Tanaka K, Yokoyama R . CXCR4 and VEGF expression in the primary site and the metastatic site of human osteosarcoma: analysis within a group of patients, all of whom developed lung metastasis. Mod Pathol. 2006; 19(5):738-45. DOI: 10.1038/modpathol.3800587. View

Yang Y, Lee Z, Wu C, Chen T, Chang C, Chen C . CXCR4 expression is associated with pelvic lymph node metastasis in cervical adenocarcinoma. Int J Gynecol Cancer. 2007; 17(3):676-86. DOI: 10.1111/j.1525-1438.2007.00841.x. View

10.

Chen Y, Jiang T, Mao A, Xu J . Esophageal cancer stem cells express PLGF to increase cancer invasion through MMP9 activation. Tumour Biol. 2014; 35(12):12749-55. DOI: 10.1007/s13277-014-2601-x. View

11.

Huang Q, Lan F, Wang X, Yu Y, Ouyang X, Zheng F . IL-1β-induced activation of p38 promotes metastasis in gastric adenocarcinoma via upregulation of AP-1/c-fos, MMP2 and MMP9. Mol Cancer. 2014; 13:18. PMC: 3937117. DOI: 10.1186/1476-4598-13-18. View

12.

Mira E, Lacalle R, Buesa J, de Buitrago G, Jimenez-Baranda S, Gomez-Mouton C . Secreted MMP9 promotes angiogenesis more efficiently than constitutive active MMP9 bound to the tumor cell surface. J Cell Sci. 2004; 117(Pt 9):1847-57. DOI: 10.1242/jcs.01035. View

13.

Laverdiere C, Hoang B, Yang R, Sowers R, Qin J, Meyers P . Messenger RNA expression levels of CXCR4 correlate with metastatic behavior and outcome in patients with osteosarcoma. Clin Cancer Res. 2005; 11(7):2561-7. DOI: 10.1158/1078-0432.CCR-04-1089. View

14.

van Kempen L, Coussens L . MMP9 potentiates pulmonary metastasis formation. Cancer Cell. 2002; 2(4):251-2. DOI: 10.1016/s1535-6108(02)00157-5. View

15.

Kager L, Zoubek A, Potschger U, Kastner U, Flege S, Kempf-Bielack B . Primary metastatic osteosarcoma: presentation and outcome of patients treated on neoadjuvant Cooperative Osteosarcoma Study Group protocols. J Clin Oncol. 2003; 21(10):2011-8. DOI: 10.1200/JCO.2003.08.132. View

16.

Muller A, Homey B, Soto H, Ge N, CATRON D, Buchanan M . Involvement of chemokine receptors in breast cancer metastasis. Nature. 2001; 410(6824):50-6. DOI: 10.1038/35065016. View

17.

Ritter J, Bielack S . Osteosarcoma. Ann Oncol. 2010; 21 Suppl 7:vii320-5. DOI: 10.1093/annonc/mdq276. View

18.

Wang X, Lu H, Urvalek A, Li T, Yu L, Lamar J . KLF8 promotes human breast cancer cell invasion and metastasis by transcriptional activation of MMP9. Oncogene. 2010; 30(16):1901-11. PMC: 3952074. DOI: 10.1038/onc.2010.563. View

19.

Egeblad M, Werb Z . New functions for the matrix metalloproteinases in cancer progression. Nat Rev Cancer. 2002; 2(3):161-74. DOI: 10.1038/nrc745. View

20.

Hiratsuka S, Nakamura K, Iwai S, Murakami M, Itoh T, Kijima H . MMP9 induction by vascular endothelial growth factor receptor-1 is involved in lung-specific metastasis. Cancer Cell. 2002; 2(4):289-300. DOI: 10.1016/s1535-6108(02)00153-8. View